- Why a Norwood biotech is outperforming every public company in Mass. this yearbizjournals.com
- Norwood biotech's shares soar on FDA news that could speed up drug approvalbizjournals.com
- In the shadow of Vertex, small cystic fibrosis-focused biotechs thrivebizjournals.com
- Norwood biotech gets first of three potential orphan drug designationsbizjournals.com
- Vertex's $1B deal with Parion expands interest into other kinds of CF drugsbizjournals.com
- Bay State’s newest Nasdaq-listed biotech, Corbus gets $5M cystic fibrosis grantbizjournals.com
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.